Search research articles
Contact Us
Filters
Showing results (161-170 of 217) with videos related to
Page
of 22
Sort By:
Transplantation and Cellular Therapy
|
March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Transplantation and Cellular Therapy
|
April 9, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report
Joseph Pidala, Carrie Kitko, Stephanie J Lee, et al.
Blood
|
January 18, 2014
Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens
Menachem Bitan, Wensheng He, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2015
Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure
Mouhab Ayas, Mary Eapen, Jennifer Le-Rademacher, et al.
Blood Advances
|
September 3, 2025
Harmonized Immune Recovery Monitoring after HCT: Evidence & Practical Guidance from the Westhafen Intercontinental Group
Taymour Hammoudi, Silvia Nucera, Alexandre G Troullioud Lucas, et al.
Bone Marrow Transplantation
|
September 4, 2023
No impact of CD34<sup>+</sup> cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622
William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Transplantation and Cellular Therapy
|
April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
Carrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.
Blood
|
August 29, 2013
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality
Joseph Pidala, Tao Wang, Michael Haagenson, et al.
Blood
|
March 30, 2016
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells
Amina Kariminia, Shernan G Holtan, Sabine Ivison, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 217) with videos related to
Sort By:
Page
of 22
Transplantation and Cellular Therapy
|
March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Transplantation and Cellular Therapy
|
April 9, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report
Joseph Pidala, Carrie Kitko, Stephanie J Lee, et al.
Blood
|
January 18, 2014
Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens
Menachem Bitan, Wensheng He, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2015
Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure
Mouhab Ayas, Mary Eapen, Jennifer Le-Rademacher, et al.
Blood Advances
|
September 3, 2025
Harmonized Immune Recovery Monitoring after HCT: Evidence & Practical Guidance from the Westhafen Intercontinental Group
Taymour Hammoudi, Silvia Nucera, Alexandre G Troullioud Lucas, et al.
Bone Marrow Transplantation
|
September 4, 2023
No impact of CD34<sup>+</sup> cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622
William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Transplantation and Cellular Therapy
|
April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
Carrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.
Blood
|
August 29, 2013
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality
Joseph Pidala, Tao Wang, Michael Haagenson, et al.
Blood
|
March 30, 2016
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells
Amina Kariminia, Shernan G Holtan, Sabine Ivison, et al.
Page
of 22